Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors

Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors
August 07, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Files Patent Infringement Suit Against Balt

Route 92 Medical filed a patent infringement suit against Balt alleging infringement of five U.S. patents protecting its Tenzing delivery technology.
July 14, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial

Route 92 Medical announced results from an independent real-world study of its HiPoint Reperfusion System and plans for a 500-patient SUMMIT RISE study.
June 18, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Appoints Medtech Industry Veterans Mitch Hill and Lucas Buchanan to its Board of Directors

Route 92 Medical names med tech industry veterans Mitch Hill and Lucas Buchanan to its board of directors.
May 21, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Results of SUMMIT MAX Clinical Trial Showing Highest First Pass Effect Ever Reported in a Randomized Endovascular Stroke Thrombectomy Study

Route 92 Medical announces results of the SUMMIT MAX randomized clinical trial and receipt of a 510(k) clearance for the HiPoint 88 Reperfusion System.
May 06, 2025 09:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical

Route 92 Medical and Q'Apel Medical have settled their patent litigation.
March 27, 2025 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Receives Australian Therapeutic Goods Administration Approval for its Portfolio of Neurovascular Interventional Products for Treating Patients with Acute Ischemic Stroke

Route 92 Medical receives Australian Therapeutic Goods Administration approval for its portfolio of neurovascular interventional products.
March 19, 2025 09:00 ET | Source: Route 92 Medical, Inc.

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

First-of-its-kind multicenter study demonstrates the utility of the Monopoint system in procedures to treat idiopathic intracranial hypertension.
September 23, 2024 09:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces $50 Million Series F Extension Equity Financing

Route 92 Medical announces $50 million series F extension equity financing to support its commercial expansion.
July 22, 2024 08:00 ET | Source: Route 92 Medical, Inc.

Route 92 Medical Announces Commercial Launch of FreeClimb 88 Catheter System

Route 92 Medical announces the commercial launch of its FreeClimb 88 catheter system.